Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the U.K.
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess, in the general diabetic population, 1) the prevalence of painful neuropathic symptoms; 2) the relationship between symptoms and clinical severity of neuropathy; and 3) the role of diabetes type, sex, and ethnicity in painful neuropathy. RESEARCH DESIGN AND METHODS: Observational study of a large cohort of diabetic patients receiving community-based health care in northwest England (n = 15,692). Painful diabetic neuropathy (PDN) was assessed using neuropathy symptom score (NSS) and neuropathy disability score (NDS). RESULTS: Prevalence of painful symptoms (NSS ≥5) and PDN (NSS ≥5 and NDS ≥3) was 34 and 21%, respectively. Painful symptoms occurred in 26% of patients without neuropathy (NDS ≤2) and 60% of patients with severe neuropathy (NDS >8). Adjusted risk of painful neuropathic symptoms in type 2 diabetes was double that of type 1 diabetes (odds ratio [OR] = 2.1 [95% CI 1.7–2.4], P < 0.001) and not affected by severity of neuropathy, insulin use, foot deformities, smoking, or alcohol. Women had 50% increased adjusted risk of painful symptoms compared with men (OR = 1.5 [1.4–1.6], P < 0.0001). Despite less neuropathy in South Asians (14%) than Europeans (22%) and African Caribbeans (21%) (P < 0.0001), painful symptoms were greater in South Asians (38 vs. 34 vs. 32%, P < 0.0001). South Asians without neuropathy maintained a 50% increased risk of painful neuropathy symptoms compared with other ethnic groups (P < 0.0001). CONCLUSIONS: One-third of all community-based diabetic patients have painful neuropathy symptoms, regardless of their neuropathic deficit. PDN was more prevalent in patients with type 2 diabetes, women, and people of South Asian origin. This highlights a significant morbidity due to painful neuropathy and identifies key groups who warrant screening for PDN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Diabetic peripheral polyneuropathy (also known as diabetic neuropathy) affects 50% of patients with diabetes [3–5]”
From A Consideration of the Psychological Aspects to Managing Patients with Painful Diabetic Neuropathy: An Insight into Pain Management Services at a Tertiary Centre in the UK (2021) · cites this paper as [4]
Experimental — accuracy not yet measuredIn the citing paper
“with previous studies suggesting that it affects 21% of patients with neuropathy (23)”
From Development of a Core Outcome Set for Studies Assessing Interventions for Diabetes-Related Foot Ulceration (2024) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global burden of diabetic foot disease
Boulton, A. J., Vileikyte, L., Ragnarson-Tennvall, G., & Apelqvist, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67698-2 · Cited by 2,566
Self-citationYoung, M. J., Boulton, A. J. M., Macleod, A. F., Williams, D. R. R., & Sonksen, P. H. (1993) · Diabetologia · doi:10.1007/bf00400697 · Cited by 1,502
Self-citationAbbott, C. A., Carrington, A. L., Ashe, H., Bath, S., Every, L. C., Griffiths, J., Hann, A. W., Hussein, A., Jackson, N., Johnson, K. E., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00698.x · Cited by 1,056
Self-citationThe Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes
Davies, M., Brophy, S., Williams, R., & Taylor, A. (2006) · Diabetes Care · doi:10.2337/dc05-2228 · Cited by 746
Tesfaye, S., Stevens, L. K., Stephenson, J. M., Fuller, J. H., Plater, M., Ionescu-Tirgoviste, C., Nuber, A., Pozza, G., & Ward, J. D. (1996) · Diabetologia · doi:10.1007/s001250050586 · Cited by 695
Bril, V., England, J., Franklin, G. M., Backonja, M., Cohen, J., Del Toro, D., Feldman, E., Iverson, D. J., Perkins, B., Russell, J. W., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182166ebe · Cited by 634
Daousi, C., MacFarlane, I. A., Woodward, A., Nurmikko, T. J., Bundred, P. E., & Benbow, S. J. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01271.x · Cited by 454
Foot complications in Type 2 diabetes: an Australian population‐based study
Tapp, R. J., Shaw, J. E., De Courten, M. P., Dunstan, D. W., Welborn, T. A., & Zimmet, P. Z. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00881.x · Cited by 193
Cabezas-Cerrato, J. (1998) · Diabetologia · doi:10.1007/s001250051063 · Cited by 192
Abbott, C. A., Garrow, A. P., Carrington, A. L., Morris, J., Van Ross, E. R., & Boulton, A. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.1869 · Cited by 171
Self-citation
Cited by
Items 501–600 of 870
Carotenoids as Antidiabetic Agents
Sahu, R., & Dewanjee, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-46459-2_14 · Cited by 8
Overcoming clinical challenges of refractory neuropathic pain
Pirvulescu, I., Biskis, A., Candido, K. D., & Knežević, N. N. (2022) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2022.2105206 · Cited by 10
Zhang, W., & Chen, L. (2022) · Brain Sciences · doi:10.3390/brainsci12101328 · Cited by 10
Daeschler, S. C., Pennekamp, A., Tsilingiris, D., Bursacovschi, C., Aman, M., Eisa, A., Böcker, A., Klimitz, F. J., Stolle, A., Kopf, S., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13020348 · Cited by 8
Pușcașu, C., Ungurianu, A., Șeremet, O. C., Andrei, C., Mihai, D. P., & Negreș, S. (2023) · Medicina · doi:10.3390/medicina59081375 · Cited by 17
“Another study comprising 15,000 diabetic individuals pointed out that 35% had painful neuropathy, with women and South Asians having an increased risk of developing symptoms of neuropathy [5].”
BackgroundEffects of Pain and Disability on Quality of Life in Patients with Diabetic Polyneuropathy
Olmez, N., Değirmenci, Y., & Keçeci, H. (2015) · Neuroscience & Medicine · doi:10.4236/nm.2015.63017 · Cited by 8
“diabetes [16].”
Chiang, S.-S., Lee, C.-L., Liu, H., Wang, J., Lee, I., Song, Y.-M., Fu, C., Li, Y., Sheu, W. H., & Lin, S. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.08.022 · Cited by 8
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neumann, S. A. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_10 · Cited by 13
Wong, C., Lee, J. S., Tam, K., Hung, H., So, W., Shum, C., Lam, C., Cheng, J., Man, S., & Auyeung, T. (2017) · Hong Kong Medical Journal · doi:10.12809/hkmj166140 · Cited by 11
Sciatic neurosteatosis: Relationship with age, gender, obesity and height
Ratner, S., Khwaja, R., Zhang, L., et al. (2017) · European Radiology · doi:10.1007/s00330-017-5087-2 · Cited by 8
Anastasiou, G., Liberopoulos, E. N., Tentolouris, N., & Παπάνας, Ν. (2024) · The International Journal of Lower Extremity Wounds · doi:10.1177/15347346241240513 · Cited by 11
Xu, J., Li, T., Li, F., QIANG, H., Wei, X., Zhan, R., & Chen, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1461790 · Cited by 11
Jiang, A., Wei, H., Chu, S., Wang, M., Yan, J., Song, X.-L., Xu, T.-L., Zhang, Z., Jin, Y., & Wang, W. (2025) · Diabetes · doi:10.2337/db24-0847 · Cited by 10
EEG neurofeedback for the treatment of neuropathic pain in the elderly—a mechanistic review
Chmiel, J., Kopańska, M., Leszek, J., Trojniak, J., & Ros, T. (2025) · GeroScience · doi:10.1007/s11357-025-01848-7 · Cited by 7
Azarboo, A., Fallahtafti, P., Javidan, A., Zareshahi, N., Giglou, H. S., Moayyed, S., Raeini, A. G., & Hemmatabadi, M. (2025) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103223 · Cited by 8
Managing people with diabetes during the cancer palliation in the era of simultaneous care
Ferrari, P., Giardini, A., Negri, E. M., Villani, G., & Preti, P. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.12.010 · Cited by 8
El-Sherbeeny, N. A., Ibrahiem, A. T., Ali, H. S., Farag, N. E., Toraih, E. A., & Zaitone, S. A. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01249-8 · Cited by 7
Role of Mechanoinsensitive Nociceptors in Painful Diabetic Peripheral Neuropathy
Nemenov, M. I., Singleton, J. R., & Premkumar, L. S. (2021) · Current Diabetes Reviews · doi:10.2174/1573399818666211208101555 · Cited by 8
Zhang, W., Chen, L., & Lou, M. (2022) · Brain Sciences · doi:10.3390/brainsci12121704 · Cited by 7
“The NSS was performed based on a questionnaire used for assessing pain or discomfort in the legs [22,24].”
MethodSato, A., Yasukochi, S., Iwanaka, N., Yamauchi, T., Tsuruta, A., Koyanagi, S., & Ohdo, S. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001856 · Cited by 8
Pető, A., Tóth, L. I., Hernyák, M., Lőrincz, H., Molnár, Á., Nagy, A. C., Lukács, M., Kempler, P., Paragh, G., Harangi, M., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306482 · Cited by 9
Heme oxygenase-1 inhibits neuropathic pain in rats with diabetic mellitus.
Kong, Q., Liu, K., Ling-xi, W., & Wang, L. (2012) · PubMed Central · doi:10.3969/j.issn.1673-5374.2012.29.010 · Cited by 7
“Diabetic neuropathic pain is typically worse at night, causing considerable interference in sleep and enjoyment of life([3]).”
BackgroundReed, C. C., Hồng, Novick, D., Lenox-Smith, & Happich (2013) · Pragmatic and Observational Research · doi:10.2147/por.s49746 · Cited by 7
Clinical features and diagnosis of diabetic polyneuropathy
Sé, A., Chernenkova, N. A., & Сурнина, З. В. (2017) · Russian Annals of Ophthalmology · doi:10.17116/oftalma2017133598-102 · Cited by 8
Hesselink, J. M. K., Kopsky, D. J., & Bhaskar, A. (2019) · Journal of Pain Research · doi:10.2147/jpr.s180792 · Cited by 7
Early diagnosis of diabetic polyneuropathy based on the results of corneal nerve fibers examination
Sé, A., Chernenkova, N. A., Сурнина, З. В., Ахмеджанова, Л. Т., Фокина, А. С., & Strokov, I. A. (2020) · Russian Annals of Ophthalmology · doi:10.17116/oftalma2020136052155 · Cited by 8
Scuteri, D., Rombolà, L., Hayashi, T., Watanabe, C., Sakurada, S., Hamamura, K., Sakurada, T., Tonin, P., Bagetta, G., Morrone, L. A., et al. (2022) · Molecules · doi:10.3390/molecules27154987 · Cited by 7
“This fragile population most often experiences chronic pain due to age-related comorbidities, such as diabetes [6] and shingles due to herpes zoster infection [7], but also injury [8], stroke [9], and rheumatic conditions, usually including neuropathic features [10–12].”
BackgroundPotaliya, U., Tak, S., & Goyal, M. K. (2023) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102725 · Cited by 8
Sinacore, D. R., Jones, M. A., & Kline, P. W. (2024) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2024.02 · Cited by 6
“The lifetime prevalence of peripheral neuropathy is estimated to be 50% among individuals with diabetes mellitus and this prevalence tends to increase with the duration of diabetes [1] .”
BackgroundGenetic Variants Influence the Development of Diabetic Neuropathy
Hajdú, N., Rácz, R., Tordai, D. Z., Békeffy, M. Z., Vági, O. E., Istenes, I., Körei, A. E., Kempler, P., & Putz, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126429 · Cited by 8
“Preceding studies had found several risk factors for neuropathic pain like female sex, smoking, age, weight, and longer diabetes duration [78–80].”
BackgroundThe role and mechanisms of matrix metalloproteinase-9 in peripheral neuropathic pain
Jia, S. Y., Tang, X.-J., Yao, S., Liu, Y., Ming, Z., & Lin, J. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1647316 · Cited by 10
Immunological mechanisms and therapeutic advances in diabetic neuropathy
Jiang, S., Zhang, L., Zhao, L., Lv, Y., Cheng, S., Liu, C., Xu, S., & Zhang, B. (2026) · Journal of Neurology · doi:10.1007/s00415-025-13594-z · Cited by 7
“Among the different types of DN, diabetic neuropathic pain (DNP) is one of the most common and clinically challenging forms [8].”
Specific regulation of mechanical nociception by Gβ5 involves GABA-B receptors
Pandey, M., Zhang, J., Adikaram, P. R., Kittock, C. M., Lue, N., Awe, A. M., Degner, K. N., Jacob, N., Staples, J., Thomas, R. E., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.134685 · Cited by 8
“Painful diabetic polyneuropathy, for example, affects as many as 100 million people worldwide (1, 2).”
BackgroundMesa-Lombardo, A., García‐Magro, N., Núñez, Á., & Martín, Y. B. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1208121 · Cited by 7
Hayashi, Y., Himeno, T., Shibata, Y., Hirai, N., Asada‐Yamada, Y., Sasajima, S., Asano‐Hayami, E., Motegi, M., Asano, S., Kato, M., et al. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14174 · Cited by 8
“Diabetic polyneuropathy (DPN) is the most common neuropathy in developed countries, affecting approximately 50% of diabetes patients 1 – 4 .”
BackgroundDiabetic Neuropathic Pain and Circadian Rhythm: A Future Direction Worthy of Study
Yang, B., Wei, W., Fang, J., Xue, Y., & Wei, J. (2024) · Journal of Pain Research · doi:10.2147/jpr.s467249 · Cited by 8
Merlin, E., Salio, C., & Ferrini, F. (2024) · Cells · doi:10.3390/cells13232024 · Cited by 13
Halting the March of Painful Diabetic Neuropathy
Haanpää, M., & Hietaharju, A. (2015) · Cited by 6
Cassidy, F. C., Lafferty, S., & Coleman, C. M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.94271 · Cited by 6
Devi, F. L. (2021) · Jurnal Penelitian Perawat Profesional · doi:10.37287/jppp.v3i1.370 · Cited by 6
Role of Intravenous Lidocaine Infusion in the Treatment of Peripheral Neuropathy
Gupta, H., Patel, A., Eswani, Z., Moore, P. W., Steib, M., Lee, C., & Kaye, A. D. (2021) · Orthopedic Reviews · doi:10.52965/001c.25567 · Cited by 10
Li, M., Yao, L., Huang, H., Zheng, H., Cao, J., Wang, G., Liu, Y., & Wang, H. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-055874 · Cited by 6
Estimating the cost of type 1 diabetes in Ireland
Sharma, S., Gillespie, P., Hobbins, A. P., & Dinneen, S. F. (2022) · Diabetic Medicine · doi:10.1111/dme.14779 · Cited by 8
Chen, Y., Wang, Y., Zhang, Y., Li, M., Zhang, W., Zhou, Y., Liu, X., Fu, J., Lu, Z., Xu, Q., et al. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108406 · Cited by 6
Painful diabetic polyneuropathy: modern approaches to diagnosis and treatment
Ахмеджанова, Л. Т., & Mandra, E. V. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-23-86-92 · Cited by 7
Parsons, B., Li, C.-T., Emir, B., & Vinik, A. I. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1509304 · Cited by 6
Grbovic, V. M., Jurišić-Škevin, A., Djukic, S., et al. (2016) · Journal of Physical Therapy Science · doi:10.1589/jpts.28.432 · Cited by 6
Rached, R. D. V. A., Hsing, W. T., & Rached, C. D. A. (2019) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.65.7.982 · Cited by 6
Neuropathic pain: mechanisms of development, principles of diagnostics and treatment
Dmytrіiev, D., Прудиус, П. Г., Zaletskaya, O., Lisak, Y., Rudnitsky, Y., & Korenchuk, N. (2019) · Pain medicine · doi:10.31636/pmjua.v4i2.1 · Cited by 6
Etiology and epidemiology of neuropathic pain
Suh, B. C. (2021) · Journal of Korean Medical Association · doi:10.5124/jkma.2021.64.7.461 · Cited by 6
CX3CR1 contributes to streptozotocin-induced mechanical allodynia in the mouse spinal cord
Ni, C.-M., Ling, B., Xu, X., Sun, H.-P., Jin, H., Zhang, Y., Cao, H., & Xu, L. (2020) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1900439 · Cited by 7
Lechleitner, M., Abrahamian, H., Francesconi, C. M., & Köfler, M. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-015-0930-4 · Cited by 6
Keratinocyte-Derived Exosomes in Painful Diabetic NeuropathyPreprint
Coy-Dibley, J. S., Jayaraj, N. D., Ren, D., Pacifico, P., Belmadani, A. A., Wang, Y., Gebis, K. K., Savas, J. N., Paller, A. S., Miller, R. J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.21.608803 · Cited by 6
Yang, D., Shu, H., Lun, Y., Li, C., & Yang, Y. (2023) · World Journal of Surgery · doi:10.1007/s00268-023-07019-z · Cited by 5
Bäckryd, E., Themistocleous, A. C., Larsson, A. O., Gordh, T., Rice, A. S. C., Tesfaye, S. H., Bennett, D., & Gerdle, B. U. C. (2024) · Scientific Reports · doi:10.1038/s41598-024-66471-6 · Cited by 8
Neuropathic pain in diabetic polyneuropathy: a 5-year prospective study
Brask‐Thomsen, P. K., Itani, M., Karlsson, P., Kristensen, A. G., Krøigård, T., Jensen, T. S., Tankişi, H., Sindrup, S. H., Finnerup, N. B., & Gylfadottir, S. S. (2025) · Pain · doi:10.1097/j.pain.0000000000003649 · Cited by 5
Henney, A. E., Frank, B., Riley, D. R. J., Anson, M., Burgess, J., Hernadez, G., Lip, G. Y. H., Malik, R. A., Tesfaye, S. H., Cuthbertson, D. J., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103489 · Cited by 7
Self-citationFrom bench to bedside: therapeutic potential of natural antioxidants in diabetic neuropathy
Zhang, Y., Yao, L., Lyu, Y., Tang, Z., Liu, X., & Duan, X. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1631678 · Cited by 8
Cellular, Molecular and Therapeutic Advances in Type 2 Diabetes Mellitus
Potdar, P. D., & Chaudhari, M. B. (2016) · Diabetes Management · Cited by 5
Han, L., Calcutt, N. A., & Zhou, X. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0614 · Cited by 5
“Pain is a frequent feature, with over 30% of T2DM surveyed at home describing some painful symptoms, including a sub-set who were yet to be diagnosed with neuropathy [81].”
Statin therapy and neuropathy in type 1 diabetes: A cross‐sectional study
Pasha, R., Kamath, A., Linn, Z., Kalteniece, A., Bashir, B., Schofield, J. D., Malik, R. A., Azmi, S., Ferdousi, M., & Soran, H. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16617 · Cited by 8
Self-citationRehman, N. U., al‐Rashida, M., Tokhi, A., Ahmed, Z. S., Subhan, F., Abbas, M., Arshid, M. A., & Rauf, K. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s269777 · Cited by 6
Preventing diabetes-related foot ulcers through early detection of peripheral neuropathy
McMorrow, R., Nubé, V. L., & Manski-Nankervis, J.-A. E. (2022) · Australian Journal of General Practice · doi:10.31128/ajgp-06-22-6456 · Cited by 12
Vieira, A. R. S. D. A., Porto, L. B., Romani, F. A. D. P., Carvalho, P. S., Pop‐Busui, R., & Pedrosa, H. C. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01036-7 · Cited by 6
Alharajin, R., AlMoaibed, H. S., & Khalifah, F. K. A. (2023) · Cureus · doi:10.7759/cureus.49317 · Cited by 5
“Also, this study's findings were lower than that estimated in a study conducted in Saudi Arabia where PDPN was reported as 65.3% [11], in Libya at 42.2% [18], in the United Kingdom at 34% [19], and in South Africa at 30.3% [20].”
ResultInfluentialDong, F., & He, X. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.06.003 · Cited by 6
Effects of insulin on peripheral nerves
Stecker, M. M., & Stevenson, M. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.03.009 · Cited by 5
Somatosensation Differences in Older Adults with and Without Diabetes, and by Age Group
Kim, Y. J., Rogers, J. C., Kwok, G., Dunn, W., & Holm, M. B. (2016) · Occupational Therapy In Health Care · doi:10.3109/07380577.2015.1136758 · Cited by 4
“Because pain is a hallmark of diabetic neuropathy (Abbott et al., 2011; Erbas et al., 2011), and neuropathy was an inclusion criterion for the study, this finding was expected.”
BackgroundForetinib mitigates cutaneous nerve fiber loss in experimental diabetic neuropathy
Daeschler, S. C., Zhang, J., Gordon, T., Borschel, G. H., & Feinberg, K. (2022) · Scientific Reports · doi:10.1038/s41598-022-12455-3 · Cited by 5
Scuteri, D., Watanabe, C., Sakurada, S., Hamamura, K., Sakurada, T., Tonin, P., Bagetta, G., & Corasaniti, M. T. (2022) · Processes · doi:10.3390/pr10071340 · Cited by 6
Transgenic Mice for the Translational Study of Neuropathic Pain and Dystonia
Scuteri, D., Hamamura, K., Watanabe, C., Tonin, P., Bagetta, G., & Corasaniti, M. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158580 · Cited by 5
“In particular, neuropathic pain is very debilitating, and neuropathies caused by comorbidities, such as diabetes, are very common, with a prevalence of 60% [2].”
BackgroundBurden of disease of chronic pain in Ecuador
Lasalvia, P., Gil-Rojas, Y., & Rosselli, D. (2023) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2023.2193689 · Cited by 5
“For diabetic neuropathy, we considered the study by Abbott et al [23] who estimated the prevalence in a group of patients diagnosed with diabetes.”
MethodDiabetic Neuropathy Collection: Treatment of Diabetic Neuropathy
Alam, U. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00784-3 · Cited by 5
Current Ideas on the Treatment Of Diabetic Neuropathies
Anderson, D., & Zochodne, D. W. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2016.1145050 · Cited by 5
Spinal cord stimulation and modulation of neuropathic pain
Vos, D. C. (2013) · doi:10.3990/1.9789036502566 · Cited by 5
Stimulating Results Signal a New Treatment Option for People Living With Painful Diabetic Neuropathy
Armstrong, D. G., & Grunberger, G. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221099542 · Cited by 5
Keratinocyte-derived extracellular vesicles in painful diabetic neuropathy
Coy-Dibley, J. S., Jayaraj, N. D., Ren, D., Pacifico, P., Belmadani, A. A., Wang, Y., Gebis, K. K., Savas, J. N., Paller, A. S., Miller, R. J., et al. (2024) · Neurobiology of Pain · doi:10.1016/j.ynpai.2024.100176 · Cited by 12
“Along with nociceptive DRG neurons, various other neuronal subpopulations terminate in the skin, both in the dermis and the epidermis (Abbott et al., 2011).”
Ventura‐Martínez, R., López, G. E. Á., Domínguez-Páez, T., et al. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00727-4 · Cited by 4
Li, L., Luo, X., Liu, Y., Jiang, Y., Chen, Y., Chen, Y., & Wang, J. (2025) · Neurology and Therapy · doi:10.1007/s40120-025-00759-1 · Cited by 8
Rabah, C. B., Petropoulos, I. N., Stettner, M., Ferdousi, M., Alam, U., Efron, N., Serag, A., & Malik, R. A. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70255 · Cited by 4
“Diabetic neuropathy is globally underdiagnosed in up to 90% of patients with diabetes [5], even though it is associated with significant morbidity due to painful neuropathy [33], foot ulceration and amputation and a twofold increase in mortality [34].”
Self-citationSmithiseth, K., Leurcharusmee, P., Sawaddiruk, P., Chattipakorn, N., & Chattipakorn, S. (2025) · Nutrition Research · doi:10.1016/j.nutres.2025.01.005 · Cited by 5
Adamczyk, W. M., Berendt, N., Trillenberg, P., Hanssen, J., Poehlmann, J., Kapitza, C., Luebke, L., Luedtke, K., Brüggemann, N., & Szikszay, T. M. (2025) · Pain · doi:10.1097/j.pain.0000000000003666 · Cited by 6
Vidyasagar, P., Farrell, S., Colorado, L. H., Dando, S., & Edwards, K. (2025) · Biomedicines · doi:10.3390/biomedicines13071675 · Cited by 6
“For example, a community-based study found that while 34% of diabetic patients reported painful symptoms, only 21% met criteria for diabetic neuropathy based on assessments such as the Neuropathy Disability Score (NDS) and Neuropathy Symptom Score (NSS) [1].”
InfluentialDhawan, S., Bongirwar, A., Muñoz‐Tudurí, M., Romesh, A. K., Kurmi, P. H., & Jankar, R. T. (2025) · Pain Practice · doi:10.1111/papr.70061 · Cited by 5
Causal Central Network Remodeling in Diabetic Neuropathy: An Integrated MR-fMRI Study
Li, X., & Gao, L. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s525219 · Cited by 4
“2,3 Notably, 25–50% of DPN patients develop neuropsychological impairments such as anxiety or depression, correlating with diminished psychomotor efficiency on cognitive assessments.”
Hagiwara, S., Jha, J. C., & Cooper, M. E. (2013) · Diabetology International · doi:10.1007/s13340-013-0148-5 · Cited by 4
“More than half of all individuals with diabetes eventually develop neuropathy [20], with a lifetime risk of one or more lower extremity amputations estimated in some populations to be up to 15 %.”
BackgroundManajemen nyeri neuropati pada pasien diabetes melitus tipe 2: Studi literatur
Pebrianti, S., Nugraha, B. A., & Shalahuddin, I. (2020) · HOLISTIK JURNAL KESEHATAN · doi:10.33024/hjk.v14i2.2828 · Cited by 4
Hébert, H. L., Veluchamy, A., Baskozos, G., Fardo, F., Ryckeghem, D. M. L. V., Pearson, E. R., Colvin, L., Crombez, G., Bennett, D., Meng, W., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11478-0 · Cited by 5
“Moreover, a number of psychological comorbidities have been associated with neuropathic pain, including sleep disturbance, anxiety and depression [11], as well as demographic factors such as older age [12] and female gender [13].”
BackgroundMolecular and Cellular Mechanisms of Neuropathic Pain in Aging
Huang, H., Wu, J., Chang, Y., Wang, H., Tian, Y., Chen, Z., Feng, J., & Wang, H. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00010 · Cited by 5
Wang, V. C., & Bačkonja, M. (2024) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001474 · Cited by 6
Benefits of Cilostazol’s Effect on Vascular and Neuropathic Complications Caused by Diabetes
Musial, D. C., Ajita, M. E., & Bomfim, G. H. S. (2024) · Medical Sciences · doi:10.3390/medsci13010001 · Cited by 7
“The prevalence of diabetic neuropathy in the general population is reported to be 49% [29], and recent studies indicate a prevalence of approximately 30% [30,31].”
Sigma-1 receptor as an emerging target for painful diabetic neuropathy—a review
Peng, Y., Zhang, Q., & Chen, S. (2025) · Exploration of neuroscience · doi:10.37349/en.2025.100680 · Cited by 4
Glial fibrillary acidic protein: a potential biomarker for small fiber neuropathy?
Hviid, C. V. B., Rasmussen, N. H., & Røikjer, J. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02500-8 · Cited by 4
“Up to 50% of all people with diabetes suffer from DPN and half of these develop neuropathic pain [2, 3].”
Indian Spices for the Management of Diabetic Foot Complications
Sumpio, G. C. B. J. (2013) · Angiology Open Access · doi:10.4172/2329-9495.1000114 · Cited by 6
“At least 50% of all the patients with diabetes develop peripheral neuropathy during the course of their disease [8].”
BackgroundDiabetic Peripheral Neuropathy: When Patients Present with Pain
Tanenberg, R. J. (2016) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2016.03.00060 · Cited by 4
Antiallodynic Effect of Piperine in Neuropathic Rats
Sánchez-Trujillo, L. A., Mendoza-Monroy, J. L., Rocha-González, H. I., et al. (2020) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-020-00047-z · Cited by 4
Jacob, L., Kaiser, M., & Kostev, K. (2021) · Primary care diabetes · doi:10.1016/j.pcd.2020.12.005 · Cited by 3
Illuri, R., Sudeep, H. V., & Shyamprasad, K. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s366609 · Cited by 6
Tanashyan, M. М., Антонова, К. В., & Раскуражев, А. А. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-17-72-80 · Cited by 5
Mapping the Journey of Patients with Painful Diabetic Peripheral Neuropathy in the Philippines
Espiritu-Picar, R., Matawaran, B. J., Lim, J. M., & Ratnasingham, P. (2022) · Acta Medica Philippina · doi:10.47895/amp.vi0.4471 · Cited by 3
“A 9-11 Relative to other countries in the South-East region, limited data on the prevalence of patients with pDPN in the Philippines are available.”
Background
Metadata
- Authors
- Abbott, C. A., Malik, R. A., van Ross, E. R. E., Kulkarni, J., & Boulton, A. J. M.
- Affiliations
- University of Manchester (GB)
- Disablement Services Centre, Withington Hospital, Manchester, U.K.
- Withington Community Hospital (GB)
- Corresponding author
- Abbott, Caroline A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-09-15
- Volume
- 34
- Issue
- 10
- Pages
- 2220-2224
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3177727
- OpenAlex
- W2162902338
- Semantic Scholar
- f503e4898de5486de267534e888652f729e9319c
- Cited by
- 868
- References
- 19
- Citations by year
- 2026: 38 · 2025: 67 · 2024: 74 · 2023: 69 · 2022: 70 · 2021: 97 · 2020: 99 · 2019: 64 · 2018: 54 · 2017: 48 · 2016: 47 · 2015: 52 · 2014: 41 · 2013: 35 · 2012: 12
- FWCI
- 19.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- e-space (Manchester Metropolitan University) (acceptedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- American Diabetes Association
- National Institute for Health and Care Research
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Keywords
- diabetic neuropathic pain, prevalence, type 2 diabetes, type 1 diabetes, sex differences, ethnicity, South Asians, neuropathy severity, neuropathic pain, neuropathy screening
- MeSH terms
- Administration, Oral, Adult, Aged, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Female, United Kingdom, Humans, Hypoglycemic Agents, Male, Middle Aged, Sex Factors, Age Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
